Zobrazeno 1 - 10
of 872
pro vyhledávání: '"F. Verdonck"'
Publikováno v:
Veterinární Medicína, Vol 55, Iss 8, Pp 359-368 (2010)
Enterohemorrhagic Escherichia coli (EHEC) serotype O157:H7 strains are associated with haemorraghic colitis and haemolytic uremic syndrome (HUS) in humans. Cattle are a reservoir of E. coli O157:H7. We studied the ability of bovine and human lactofer
Externí odkaz:
https://doaj.org/article/0fe6a9ee3f084845ae21f479071945ce
Autor:
Rima M. Saliba, Amin M. Alousi, Joseph Pidala, Mukta Arora, Stephen R. Spellman, Michael T. Hemmer, Tao Wang, Camille Abboud, Sairah Ahmed, Joseph H. Antin, Amer Beitinjaneh, David Buchbinder, Michael Byrne, Jean-Yves Cahn, Hannah Choe, Rabi Hanna, Peiman Hematti, Rammurti T. Kamble, Carrie L. Kitko, Mary Laughlin, Lazaros Lekakis, Margaret L. MacMillan, Rodrigo Martino, Parinda A. Mehta, Taiga Nishihori, Sagar S. Patel, Miguel-Angel Perales, Hemalatha G. Rangarajan, Olov Ringdén, Joseph Rosenthal, Bipin N. Savani, Kirk R. Schultz, Sachiko Seo, Takanori Teshima, Marjolein van der Poel, Leo F. Verdonck, Daniel Weisdorf, Baldeep Wirk, Jean A. Yared, Jeffrey Schriber, Richard E. Champlin, Stefan O. Ciurea
Publikováno v:
Transplantation and Cellular Therapy, 28(10), 681-693. Elsevier
Post-transplantation cyclophosphamide (PTCy) has been shown to effectively control graft-versus-host disease (GvHD) in haploidentical (Haplo) transplantations. In this retrospective registry study, we compared GvHD organ distribution, severity, and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356fa5e8353cd467a9f1e9db90c4ac2c
https://doi.org/10.1016/j.jtct.2022.07.013
https://doi.org/10.1016/j.jtct.2022.07.013
Autor:
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernandez-Boluda, Sergio A. Giralt, Jeanne M. Palmer, Robert Peter Gale, Zachariah DeFilipp, David Marks, Marjolein W.M van der Poel, Leo F. Verdonck, Minoo Battiwalla, Miguel A. Díaz, Vikas Gupta, Haris Ali, Mark R Litzow, Hillard M Lazarus, Usama Gergis, Asad Bashey, Jane L Liesveld, Shahrukh Hashmi, Jeffrey J. Pu, Amer Beitinjaneh, Christopher N Bredeson, David A Rizzieri, Bipin N Savani, Muhammad Bilal Abid, Siddhartha Ganguly, Vaibhav Agrawal, Vera Ulrike, Baldeep Wirk, Tania Jain, Corey S. Cutler, Mahmoud Aljurf, Tamila Kindwall-Keller, Mohamed A Kharfan-Dabaja, Gerhard C. Hildebrandt, Attaphol Pawarode, Melhem M Solh, Jean A. Yared, Michael R. Grunwald, Sunita Nathan, Taiga Nishihori, Sachiko Seo, Bart L Scott, Ryotaro Nakamura, Betul Oran, Tomasz Czerw, Ibrahim Yakoub-Agha, Wael Saber
Publikováno v:
Blood advances.
To develop a prognostic model for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT) for myelofibrosis (MF). We examined 623 patients undergoing allo-HCT between 2000 - 2016 in the USA (CIBMTR cohort). A Cox multivariab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d6bc9f8516a9a0c63948113e4e8372
https://doi.org/10.1182/bloodadvances.2023009886
https://doi.org/10.1182/bloodadvances.2023009886
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 1. Multivariate analysis of late relapse, transplant-related mortality, overall survival after HCT for each disease (AML, ALL, CML, MDS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8b6bb0ec143b555d4baa55cd9d07bc
https://doi.org/10.1158/1078-0432.22459019.v1
https://doi.org/10.1158/1078-0432.22459019.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Purpose: Malignancy relapse remains a major obstacle for successful allogeneic hematopoietic cell transplantation (HCT). Chronic graft-versus-host disease (cGVHD) is associated with fewer relapses. However, when studying effects of cGVHD on relapse,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1562e3003d7ce693a7bac43e825778d3
https://doi.org/10.1158/1078-0432.c.6524114.v1
https://doi.org/10.1158/1078-0432.c.6524114.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 4. Multivariate analysis showing impact of cGVHD characteristics on treatment related mortality, disease free survival, overall survival in patients with AML, ALL, MDS who developed cGVHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96a29a4f89ff9eb180a33441e9c479c0
https://doi.org/10.1158/1078-0432.22459010.v1
https://doi.org/10.1158/1078-0432.22459010.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 2. Multivariate analysis showing impact of cGVHD characteristics in CML patients on relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd075a41ef6607b9609e016590c0139a
https://doi.org/10.1158/1078-0432.22459016
https://doi.org/10.1158/1078-0432.22459016
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 3. Multivariate analysis showing impact of cGVHD characteristics on treatment related mortality, disease free survival and overall survival in patients with CML who developed cGVHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f3f162450909dadf1eee374d2d4530
https://doi.org/10.1158/1078-0432.22459013.v1
https://doi.org/10.1158/1078-0432.22459013.v1
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Figure 1. Cumulative incidence of cGVHD, relapse and death in patients with AML, ALL, CML, MDS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff0a47fd6e908c56333b879a03134c9
https://doi.org/10.1158/1078-0432.22459022.v1
https://doi.org/10.1158/1078-0432.22459022.v1
Autor:
Vijaya Raj Bhatt, Rodrigo Martino, Martin S. Tallman, Rafael Madero-Marroquin, Siddhartha Ganguly, Michael R. Grunwald, Mahmoud Aljurf, Stefan O. Ciurea, Ankit Kansagra, Taiga Nishihori, Brenda M. Sandmaier, Jacob M. Rowe, Alexandra Gomez-Arteaga, Amer Assal, Jan Cerny, Gerhard C. Hildebrandt, Shahinaz M. Gadalla, Jonathan Sanchez, Shahrukh K. Hashmi, Mei-Jie Zhang, Christopher Bredeson, Hillard M. Lazarus, Leo F. Verdonck, Akshay Sharma, Paul Castillo, Richard F. Olsson, Wael Saber, Fotios V. Michelis, Sachiko Seo, Kamal Menghrajani, Christopher S. Hourigan, Hongtao Liu, Ran Reshef, Michael Byrne, Sunita Nathan, Partow Kebriaei, Hai-Lin Wang, Lohith Gowda, Melhem Solh, Maxwell M. Krem, Zachariah DeFilipp, Yanming Zhang, Sherif M Badawy, Robert Peter Gale, Nosha Farhadfar, Ulrike Bacher, David A. Rizzieri, Nelli Bejanyan, Christopher G. Kanakry, Bipin N. Savani, Mark R. Litzow, Khalid Bo-Subait, Daniel J. Weisdorf, Saurabh Chhabra, Farhad Khimani, Celalettin Ustun
Publikováno v:
Blood Advances. 6:828-847
Little is known about whether risk classification at diagnosis predicts post-hematopoietic cell transplantation (HCT) outcomes in patients with acute myeloid leukemia (AML). We evaluated 8709 patients with AML from the CIBMTR database, and after sele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21257a5f341df64c6305ea812a34ea30
https://doi.org/10.1182/bloodadvances.2021004881
https://doi.org/10.1182/bloodadvances.2021004881